1
|
Keisala J, Jarva E, Comparcini D, Simonetti V, Cicolini G, Unsworth J, Tomietto M, Mikkonen K. Factors influencing nurses and nursing students' attitudes towards vaccinations: A cross-sectional study. Int J Nurs Stud 2025; 162:104963. [PMID: 39631166 DOI: 10.1016/j.ijnurstu.2024.104963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 10/30/2024] [Accepted: 11/21/2024] [Indexed: 12/07/2024]
Abstract
BACKGROUND Vaccination hesitancy remains the main obstacle to improving vaccination coverage. Influenza and COVID-19 vaccination coverage among healthcare professionals is essential. It is crucial to study the vaccination attitudes of healthcare professionals as they significantly influence the vaccination attitudes and behaviour of the rest of the population. OBJECTIVE The aim of this study was to describe the attitudes of Finnish nurses and nursing students towards COVID-19 and Influenza vaccination and explain what factors influence these attitudes. DESIGN A cross-sectional study. SETTING AND PARTICIPANTS A total of 1353 nurses from five hospital organisations and 580 nursing students from eight Universities of Applied Sciences participated in the survey. Participants were invited to complete the questionnaire through Webropol between March and September 2023. METHODS To collect data anonymously, a self-reported web-based questionnaire combining the Vaccination Attitude Examination (VAX) scale and Bergen's Social Media Addiction (BSMA) scale was used. K-means cluster analysis was performed to describe vaccination attitude profiles. RESULTS Four distinct vaccination attitude profiles were identified: Profile A - Confident Pro-Vaccine (n = 605) exhibited low hesitancy, with high confidence in vaccine safety and effectiveness; Profile B - Cautiously Pro-Vaccine (n = 764) showed moderate hesitancy, mainly concerned about unforeseen future effects; Profile C - Hesitant with Mistrust (n = 405) expressed high hesitancy, with significant worries about vaccine safety and mistrust in health authorities; and Profile D - Strongly Vaccine-Hesitant (n = 159) demonstrated very high hesitancy, marked by strong beliefs in potential long-term negative effects of vaccination. Significant differences in VAX-scale mean scores were found between the profiles, ranging from 1.27 for Profile A to 6.65 for Profile D. Overall, nursing students were more hesitant than practising nurses, with students being overrepresented in the more hesitant profiles. Clinical training in a COVID-19 unit was associated with more favourable vaccination attitudes among nursing students. The uptake of the full series of COVID-19 and annual Influenza vaccines was generally high in the sample (90.8 % and 87 %, respectively). However, a clear pattern between specific social media use and vaccination attitudes was not found. Major concerns related to vaccine hesitancy focused on the uncertainty of vaccines' long-term effects. CONCLUSION This study provides valuable insights into the complex nature of vaccination hesitancy among nurses and nursing students. These findings underscore the need for targeted interventions to address underlying concerns and promote vaccine acceptance within this demographic. In future research, it would be essential to gather more in-depth knowledge, particularly regarding nursing students' attitudes towards vaccination and the factors influencing them.
Collapse
Affiliation(s)
- Jeremia Keisala
- Research Unit of Health Sciences and Technology, University of Oulu, Oulu, Finland
| | - Erika Jarva
- Research Unit of Health Sciences and Technology, University of Oulu, Oulu, Finland.
| | - Dania Comparcini
- Interdisciplinary Department of Medicine, "Aldo Moro" University of Bari, Bari, Italy.
| | - Valentina Simonetti
- Department of Innovative Technologies in Medicine & Dentistry, "G.d'Annunzio" University of Chieti, Pescara, Italy.
| | - Giancarlo Cicolini
- Department of Innovative Technologies in Medicine & Dentistry, "G.d'Annunzio" University of Chieti, Pescara, Italy.
| | - John Unsworth
- Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom; University of Bari, Aldo Moro, Italy.
| | - Marco Tomietto
- Research Unit of Health Sciences and Technology, University of Oulu, Oulu, Finland; Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.
| | - Kristina Mikkonen
- Research Unit of Health Sciences and Technology, University of Oulu, Oulu, Finland; Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
| |
Collapse
|
2
|
González-Cueto E, de la Fuente J, López-Camacho C. Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective. Front Immunol 2024; 15:1384442. [PMID: 38947333 PMCID: PMC11211597 DOI: 10.3389/fimmu.2024.1384442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Accepted: 06/03/2024] [Indexed: 07/02/2024] Open
Abstract
The One Health approach, which integrates the health of humans, animals, plants, and ecosystems at various levels, is crucial for addressing interconnected health threats. This is complemented by the advent of mRNA vaccines, which have revolutionized disease prevention. They offer broad-spectrum effectiveness and can be rapidly customized to target specific pathogens. Their utility extends beyond human medicine, showing potential in veterinary practices to control diseases and reduce the risk of zoonotic transmissions. This review place mRNA vaccines and One Health in the context of tick-borne diseases. The potential of these vaccines to confer cross-species immunity is significant, potentially disrupting zoonotic disease transmission cycles and protecting the health of both humans and animals, while reducing tick populations, infestations and circulation of pathogens. The development and application of mRNA vaccines for tick and tick-borne pathogens represent a comprehensive strategy in global health, fostering a healthier ecosystem for all species in our interconnected world.
Collapse
Affiliation(s)
| | - José de la Fuente
- SaBio, Instituto de Investigación en Recursos Cinegéticos (IREC)-CSIC-UCLM-JCCM, Ciudad Real, Spain
- Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States
| | | |
Collapse
|
3
|
Nham E, Yoon JG, Choi MJ, Seo YB, Lee J, Choi WS, Hyun H, Seong H, Noh JY, Song JY, Kim WJ, Cheong HJ. Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in Korea. J Korean Med Sci 2024; 39:e45. [PMID: 38317446 PMCID: PMC10843970 DOI: 10.3346/jkms.2024.39.e45] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 11/28/2023] [Indexed: 02/07/2024] Open
Abstract
BACKGROUND In Korea, there are no surveillance programs for vaccines that are not included in the national immunization program (NIP), and vaccine safety monitoring in the adult population is inadequate. This study aimed to establish a safety monitoring system for non-NIP vaccines in adults. METHODS Frequently administered non-NIP vaccines were selected. Individuals were included if they received at least one of the selected vaccines at a participating institution and provided informed consent. Solicited and unsolicited adverse events were monitored using questionnaires sent through text messages on days 1, 3, 7, 28, and 90 post-vaccination. Selected adverse events of special interest (AESIs) were monitored monthly by retrospective review of electronic medical records. Causality was assessed according to the Korea Disease Control and Prevention Agency guidelines. RESULTS Four vaccines (tetanus-diphtheria-pertussis [Tdap], pneumococcal conjugate 13-valent [PCV13], live zoster vaccine [ZVL], and recombinant zoster vaccine [RZV]) were selected, and their safety profiles were monitored at four tertiary hospitals and 10 primary care clinics. The response rates of the questionnaires on post-vaccination days 1, 7, 28, and 90 were 99.2%, 93.6%, 81.0%, and 48.7%, respectively. Of 555 AESI identified over 10 months, 10 cases received one of the selected non-NIP vaccines within 90 days of the event. CONCLUSION We are establishing the first safety monitoring system for selected non-NIP vaccines in Korea since September 2022 and report its progress as of July 2023. However, continuous government support is essential for its maintenance and improvement.
Collapse
Affiliation(s)
- Eliel Nham
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Jin Gu Yoon
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Min Joo Choi
- Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea
| | - Yu Bin Seo
- Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
| | - Jacob Lee
- Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
| | - Won Suk Choi
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Hakjun Hyun
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Hye Seong
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Ji Yun Noh
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Joon Young Song
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Woo Joo Kim
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea
| | - Hee Jin Cheong
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.
| |
Collapse
|